At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

• Sponsor: Sanguine Biosciences (Industry)
• Overall Status: Recruiting
• CT.gov ID: NCT01931644
• Collaborator: (none)
• Enrollment: 20,000
• Location: 1
• Duration (Months): 329
• Patients Per Site Per Month: 60.8

Study Details

Study Description

Brief Summary

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Condition or Disease	Intervention/Treatment	Phase
All Diagnosed Health Conditions; ADD/ADHD; Alopecia Areata; Ankylosing Spondylitis; Asthma; Atopic Dermatitis Eczema; Beta Thalassemia; Bipolar Disorder; Breast Cancer; Celiac Disease; Cervical Cancer; Chronic Inflammatory Demyelinating Polyneuropathy; Chronic Kidney Diseases; Chronic Obstructive Pulmonary Disease; Colon Cancer; Colorectal Cancer; Crohn's Disease; Cystic Fibrosis; Depression; Diabetes Mellitus; Duchenne Muscular Dystrophy; Endometriosis; Epilepsy; Facioscapulohumeral Muscular Dystrophy; G6PD Deficiency; General Anxiety Disorder; Hepatitis B; Hereditary Hemorrhagic Telangiectasia; HIV/AIDS; Human Papilloma Virus; Huntington's Disease; Idiopathic Thrombocytopenic Purpura; Insomnia; Kidney Cancer; Leukemia; Lung Cancer; Lupus Nephritis; Lymphoma; Melanoma; Multiple Myeloma; Multiple Sclerosis; Myositis; Myotonic Dystrophy; Ovarian Cancer; Pancreatic Cancer; Parkinson's Disease; Polycystic Kidney Diseases; Prostate Cancer; Psoriasis; Psoriatic Arthritis; Rosacea; Scleroderma; Sickle Cell Anemia; Sickle Cell Trait; Sjogren's Syndrome; Skin Cancer; Spinal Muscular Atrophy; Systemic Lupus Erythematosus; Thrombotic Thrombocytopenic Purpura; Trisomy 21; Ulcerative Colitis

Detailed Description

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 20000 participants
• Observational Model: Cohort
• Time Perspective: Cross-Sectional
• Official Title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
• Study Start Date: Jul 1, 2013
• Anticipated Primary Completion Date: Aug 1, 2025
• Anticipated Study Completion Date: Dec 1, 2040

Arms and Interventions

Arm	Intervention/Treatment
Health Condition Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

Outcome Measures

Primary Outcome Measures

1. Biospecimen & Clinical Data Collection [10 years]

   To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 100 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• All adults 18-100 years old

• Able to provide proof of diagnosis

• Live in USA

Exclusion Criteria:

• Younger than 18 years old

• Receipt of blood products within 30 days of study blood collection

• Receipt of investigational drug within 30 days of study blood collection

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Sanguine Biosciences	Los Angeles	California	United States	91403

Sponsors and Collaborators

• Sanguine Biosciences

Investigators

• Principal Investigator: Houman Hemmati, MD, Sanguine Biosciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Sanguine Biosciences
• ClinicalTrials.gov Identifier: NCT01931644
• Other Study ID Numbers: SAN-BB-01
• First Posted: Aug 29, 2013
• Last Update Posted: Oct 8, 2019
• Last Verified: Oct 1, 2019

• Keywords provided by Sanguine Biosciences: ADD/ADHD; Alopecia Areata; Ankylosing Spondylitis; Asthma; Atopic Dermatitis Eczema; Beta Thalassemia; Bipolar Disorder; Breast Cancer; Celiac Disease; Cervical Cancer; Chronic Inflammatory Demyelinating Polyneuropathy; Chronic Kidney Diseases; Chronic Obstructive Pulmonary Disease; Colon Cancer; Colorectal Cancer; Crohn's Disease; Cystic Fibrosis; Depression; Diabete Mellitus; Duchenne Muscular Dystrophy; Endometriosis; Epilepsy; Facioscapulohumeral Muscular Dystrophy; G6PD Deficiency; General Anxiety Disorder; Hepatitis B; Hereditary Hemorrhagic Telangiectasia; HIV/AIDS; Human Papilloma Virus; Huntington's Disease; Idiopathic Thrombocytopenic Purpura; Insomnia; Kidney Cancer; Leukemia; Lung Cancer; Lupus Nephritis; Lymphoma; Melanoma; Multiple Myeloma; Multiple Sclerosis; Myositis; Myotonic Dystrophy; Ovarian Cancer; Pancreatic Cancer; Parkinson's Disease; Polycystic Kidney Diseases; Prostate Cancer; Psoriasis; Psoriatic Arthritis; Rosacea; Scleroderma; Sickle Cell Anemia; Sickle Cell Disease; Sickle Cell Trait; Sjogren's Syndrome; Skin Cancer; Spinal Muscular Atrophy; Systemic Lupus Erythematosus; Thrombotic Thrombocytopenic Purpura; Trisomy 21; Ulcerative Colitis
• Additional relevant MeSH terms: Hepatitis B; Spondylitis; Acquired Immunodeficiency Syndrome; HIV Infections; Prostatic Neoplasms; Colorectal Neoplasms; Melanoma; Multiple Myeloma; Pancreatic Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms; Colonic Neoplasms; Kidney Neoplasms; Carcinoma, Renal Cell; Skin Neoplasms; Papilloma; Arthritis; Muscular Dystrophies; Spondylarthritis; Arthritis, Psoriatic; Muscular Dystrophy, Duchenne; Spondylitis, Ankylosing; Sjogren's Syndrome; Myositis; Myotonic Dystrophy; Muscular Dystrophy, Facioscapulohumeral; Hepatitis; Cystic Fibrosis; Crohn Disease; Colitis; Colitis, Ulcerative; Celiac Disease; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive; Parkinson Disease; Multiple Sclerosis; Epilepsy; Huntington Disease; Muscular Atrophy; Polyneuropathies; Muscular Atrophy, Spinal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Down Syndrome; Kidney Diseases; Renal Insufficiency, Chronic; Endometriosis; Nephritis; Lupus Nephritis; Polycystic Kidney Diseases; Telangiectasis; Telangiectasia, Hereditary Hemorrhagic; Thalassemia; Purpura; Purpura, Thrombocytopenic; Anemia, Sickle Cell; beta-Thalassemia; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Glucosephosphate Dehydrogenase Deficiency; Sickle Cell Trait; Dermatitis, Atopic; Psoriasis; Dermatitis; Eczema; Lupus Erythematosus, Systemic; Alopecia; Alopecia Areata; Scleroderma, Systemic; Scleroderma, Diffuse; Rosacea; Disease; Sclerosis; Fibrosis; Atrophy; Trisomy; Depression; Bipolar Disorder; Anxiety Disorders

Study Results

No Results Posted as of Oct 8, 2019